Cogent Biosciences, Inc. (COGT) Social Stream
COGENT BIOSCIENCES INC (COGT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering COGT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 7 | $31 | $15 | $21.428 | $5.25 | 308.15% |
| 2022-02-08 | 7 | $31 | $14 | $20.571 | $5.25 | 291.83% |
| 2022-03-16 | 7 | $31 | $14 | $20.714 | $5.25 | 294.55% |
| 2022-05-10 | 6 | $23 | $14 | $19 | $5.25 | 261.9% |
| 2022-06-09 | 6 | $23 | $14 | $18.166 | $5.25 | 246.02% |
| 2022-06-17 | 6 | $23 | $15 | $18.333 | $5.25 | 249.2% |
| 2022-07-27 | 7 | $23 | $15 | $17.857 | $5.25 | 240.13% |
| 2022-08-08 | 7 | $23 | $15 | $18.571 | $5.25 | 253.73% |
| 2022-08-09 | 6 | $22 | $15 | $19.5 | $5.25 | 271.43% |
| 2022-11-02 | 5 | $28 | $15 | $20.5 | $5.25 | 290.48% |
| 2022-11-14 | 6 | $28 | $15 | $20.5 | $5.25 | 290.48% |
| 2022-12-12 | 6 | $28 | $15 | $20 | $5.25 | 280.95% |
| 2022-12-14 | 7 | $28 | $18 | $21.857 | $5.25 | 316.32% |
| 2023-02-07 | 7 | $28 | $18 | $22.142 | $5.25 | 321.75% |
| 2023-03-14 | 8 | $28 | $18 | $22.285 | $5.25 | 324.48% |
| 2023-03-27 | 8 | $28 | $18 | $23 | $5.25 | 338.1% |
| 2023-04-25 | 8 | $28 | $18 | $22.875 | $5.25 | 335.71% |
| 2023-04-28 | 9 | $28 | $18 | $22.555 | $5.25 | 329.62% |
| 2023-06-04 | 9 | $28 | $18 | $22.333 | $5.25 | 325.39% |
| 2023-06-05 | 9 | $28 | $18 | $22.111 | $5.25 | 321.16% |
| 2023-07-26 | 9 | $27 | $18 | $22.222 | $5.25 | 323.28% |
| 2023-08-08 | 9 | $27 | $18 | $22 | $5.25 | 319.05% |
| 2023-11-13 | 9 | $27 | $18 | $22.111 | $5.25 | 321.16% |
| 2023-12-08 | 10 | $27 | $18 | $21.7 | $5.25 | 313.33% |
| 2023-12-11 | 10 | $27 | $15 | $20.5 | $5.25 | 290.48% |
| 2023-12-15 | 10 | $26 | $5 | $17.6 | $5.25 | 235.24% |
The Trend in the Analyst Price Target
COGT's average price target has moved down $0.57 over the prior 19 months.
Over the past 46 weeks, COGT's average upside potential has been 129.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-28 | 9 | 28 | 18 | 22.555 | 10.76 | 109.62% |
| 2023-06-13 | 9 | 27 | 18 | 22.222 | 12.84 | 73.07% |
| 2023-10-17 | 9 | 27 | 18 | 22.111 | 9.35 | 136.48% |
| 2023-12-11 | 10 | 27 | 5 | 19.000 | 4.06 | 367.98% |
| 2023-12-15 | 10 | 26 | 5 | 17.600 | 4.88 | 260.66% |
COGT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 34 months, COGT's average broker recommendation rating improved by 0.09.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, COGENT BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 2897.49% of them.
- In the context of all US stocks, COGENT BIOSCIENCES INC's average analyst price target is greater than 826.24% of them.
- In terms of how COGENT BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 2670.4% of that group.
- In terms of how COGENT BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1083.49% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COGENT BIOSCIENCES INC are UBX, FIXX, and BTAI.
View All Top Stocks by Price Target
What is the outlook for COGT? Use POWR Ratings for clearer insight into price direction.